Healthcare | May 08, 2024
Sumitomo Corporation makes full-scale entry into private clinic business in fast-growing southeast Asia
Investing in Malaysia's largest clinic operator to expand the healthcare business
Investing in Malaysia's largest clinic operator to expand the healthcare business
Sales reflect continued strong growth in oncology and vaccines
Acquisition of exclusive commercialization rights for European markets
iSolveSM information on demand is the result of our focus on customer relationship
An accomplished R&D leader and champion of the application of AI to drug discovery
This turn valve is considered revolutionary because it supports back-to-back drug infusion through the same device
SyntheticGestalt will develop a pre-trained AI model to discover synthesizable drug-like hit candidates
Transaction delivers KarXT, a first-in-class M1/ M4 muscarinic receptor agonist with differentiated efficacy and safety
The new ECO grade is made using renewable feedstock
The product has been in-licensed from Strides and will be commercialized by Amneal
Subscribe To Our Newsletter & Stay Updated
